StockData

Vivos Inc (RDGL) stock

RDGLOTCSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 9/30
$0.05−0.00 (-2.51%)

Close on Oct 19, 2026Market cap $23.44MP/E –Yield –

Vivos gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Vivos's gross profit for the twelve months ending Jun 30, 2026 was -$25.66K. For fiscal 2025 it was -$59.76K. The highest annual figure on record is $329.56K in fiscal 2011.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$59.76K–
FY2024Dec 31, 2024-$2.98K–
FY2023Dec 31, 2023-$6.04K-178.2%
FY2022Dec 31, 2022$7.72K+167.4%
FY2021Dec 31, 2021$2.89K+107.4%
FY2020Dec 31, 2020$1.39K-59.9%
FY2019Dec 31, 2019$3.47K-57.2%
FY2016Dec 31, 2016$8.11K-65.7%
FY2015Dec 31, 2015$23.63K+2.7%
FY2014Dec 31, 2014$23.00K-34.8%
FY2013Dec 31, 2013$35.27K-79.9%
FY2012Dec 31, 2012$175.15K-46.9%
FY2011Dec 31, 2011$329.56K+13.5%
FY2010Dec 31, 2010$290.48K–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.72K–
Q1 FY2026Mar 31, 2026-$8.02K–
Q4 FY2025Dec 31, 2025-$3.11K–
Q3 FY2025Sep 30, 2025-$12.82K-1285.5%
Q2 FY2025Jun 30, 2025-$34.75K-1377.7%
Q1 FY2025Mar 31, 2025-$9.08K–
Q4 FY2024Dec 31, 2024-$5.29K–
Q3 FY2024Sep 30, 2024$1.08K-84.6%
Q2 FY2024Jun 30, 2024$2.72K–
Q1 FY2024Mar 31, 2024-$1.50K–
Q4 FY2023Dec 31, 2023-$9.00K–
Q3 FY2023Sep 30, 2023$7.00K–
Q2 FY2023Jun 30, 2023-$2.50K-129.5%
Q1 FY2023Mar 31, 2023-$1.54K-115.4%
Q4 FY2022Dec 31, 2022-$4.23K–
Q3 FY2022Sep 30, 2022-$6.54K-173.5%
Q2 FY2022Jun 30, 2022$8.48K–
Q1 FY2022Mar 31, 2022$10.00K–
Q4 FY2021Dec 31, 2021-$6.00K–
Q3 FY2021Sep 30, 2021$8.89K–

More Vivos figures

See a number that looks wrong?